Henry Schein, Inc. (HSIC)
NASDAQ: HSIC · Real-Time Price · USD
73.44
-1.09 (-1.47%)
At close: Jul 11, 2025, 4:00 PM
73.42
-0.02 (-0.02%)
After-hours: Jul 11, 2025, 4:50 PM EDT
Henry Schein Revenue
Henry Schein had revenue of $3.17B in the quarter ending March 29, 2025, a decrease of -0.13%. This brings the company's revenue in the last twelve months to $12.67B, up 1.75% year-over-year. In the year 2024, Henry Schein had annual revenue of $12.67B with 2.71% growth.
Revenue (ttm)
$12.67B
Revenue Growth
+1.75%
P/S Ratio
0.73
Revenue / Employee
$506,760
Employees
25,000
Market Cap
8.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 12.67B | 334.00M | 2.71% |
| Dec 30, 2023 | 12.34B | -308.00M | -2.44% |
| Dec 31, 2022 | 12.65B | 246.00M | 1.98% |
| Dec 25, 2021 | 12.40B | 2.28B | 22.55% |
| Dec 26, 2020 | 10.12B | 133.20M | 1.33% |
| Dec 28, 2019 | Pro | Pro | Pro |
| Dec 29, 2018 | Pro | Pro | Pro |
| Dec 30, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 26, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
HSIC News
- 5 weeks ago - Updated: Henry Schein to Participate in Upcoming Investor Conference in June - Business Wire
- 7 weeks ago - Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10% - Business Wire
- 7 weeks ago - Henry Schein Post Earnings Review - Seeking Alpha
- 2 months ago - Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors - Business Wire
- 2 months ago - Henry Schein to Participate in Upcoming Investor Conference in June - Business Wire
- 2 months ago - These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results - Benzinga
- 2 months ago - Henry Schein to Participate in Upcoming Investor Conferences in May - Business Wire
- 2 months ago - Henry Schein, Inc. (HSIC) Q1 2025 Earnings Call Transcript - Seeking Alpha